A Comparative Study on the Biological Activities of a Synthetic Peptide (Acetyl Hexapeptide-3) and a Natural Bee Product (Apilarnil): Antioxidant Capacity, Enzyme Inhibitory Activities, and Cytotoxicity
Journal of Apitherapy and Nature · 31.07.2026 · 9 (2) · 201-212
DOI: 10.35206/jan.1944650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Apitherapy and Nature, online erschienen am 31.07.2026. Verfasst von Sibel Dikmen Küçük und 1 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Scientific and Technological Research Council of Türkiye.
Abstract (Originalsprache)
Skin aging involves the progressive dysregulation of extracellular matrix-degrading enzymes and oxidative stress pathways, driving demand for biologically characterized cosmeceutical ingredients. This study provides the first direct comparative evaluation of apilarnil , a lyophilized drone larvae-derived bee product (Apis mellifera) and acetyl hexapeptide-3 (Argireline®; Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), a synthetic neurotransmitter inhibitor peptide, with respect to total antioxidant capacity, elastase, collagenase, and human tyrosinase inhibitory activities, and cytotoxicity toward HaCaT human keratinocytes. Compositional characterization of apilarnil revealed a protein-rich profile (42.67 g/100 g) containing 16 amino acids, multiple vitamins, and mineral constituents. Acetyl hexapeptide-3 exhibited higher total antioxidant capacity (5304.7 ± 103.9 µM Trolox equivalents) compared to apilarnil (645.3 ± 23.3 µM TE), attributable to the abundance of electron-donating residues in its defined sequence. Acetyl hexapeptide-3 also produced potent, concentration-dependent inhibition of elastase (IC₅₀ = 1.534 mg/mL) and collagenase (IC₅₀ = 0.00811 mg/mL), whereas apilarnil displayed a biphasic hormetic dose–response for both enzymes, with low-dose activation followed by high-dose inhibition. Neither compound showed an apparent inhibitory effect on human tyrosinase in a single preliminary experiment (n = 1); given the lack of statistical replication, this finding should be considered exploratory and requires confirmatory replication. Cytotoxicity assessment demonstrated that apilarnil was non-toxic across all tested concentrations (0.3125–20 mg/mL; viability >90%), while acetyl hexapeptide-3 exhibited concentration-dependent cytotoxicity (CC₅₀ = 5.34% v/v). These findings reveal complementary bioactivity profiles between the two compounds, suggesting potential value in further investigating their combined use in cosmeceutical formulations.
Förderung
- Scientific and Technological Research Council of Türkiye
Zitieren
APA
Küçük, S. D., & Kekeçoğlu, M. (2026). A Comparative Study on the Biological Activities of a Synthetic Peptide (Acetyl Hexapeptide-3) and a Natural Bee Product (Apilarnil): Antioxidant Capacity, Enzyme Inhibitory Activities, and Cytotoxicity. Journal of Apitherapy and Nature, 9(2), 201-212. https://doi.org/10.35206/jan.1944650
Vancouver
Küçük SD, Kekeçoğlu M. A Comparative Study on the Biological Activities of a Synthetic Peptide (Acetyl Hexapeptide-3) and a Natural Bee Product (Apilarnil): Antioxidant Capacity, Enzyme Inhibitory Activities, and Cytotoxicity. Journal of Apitherapy and Nature. 2026;9(2):201-212. doi:10.35206/jan.1944650
BibTeX
@article{Kk2026,
author = {Küçük, Sibel Dikmen and Kekeçoğlu, Meral},
title = {A Comparative Study on the Biological Activities of a Synthetic Peptide (Acetyl Hexapeptide-3) and a Natural Bee Product (Apilarnil): Antioxidant Capacity, Enzyme Inhibitory Activities, and Cytotoxicity},
journal = {Journal of Apitherapy and Nature},
year = {2026},
volume = {9},
number = {2},
pages = {201--212},
doi = {10.35206/jan.1944650}
}
EUVIMED